« Return to News | CROs/Service Providers

The Hamner Institutes for Health Sciences partners with QPS Holdings

Wednesday, February 20, 2013 10:26 AM

The Hamner Institutes for Health Sciences, a nonprofit research organization focused on translational safety sciences, and QPS Holdings, a Newark, Delaware-based CRO, have announced the launch of QPS Hepatic Biosciences, a center of excellence for cell based research and services. 

Hepatic Biosciences is a new division within the QPS DMPK department and will specialize in hepatocyte research, drug metabolism, drug transporter sciences and in vitro drug-drug interactions. The scientific discipline of this new operation at The Hamner Institutes is jointly led by Drs. Edward LeCluyse, associate investigator at The Hamner, and Caroline Lee, director of drug metabolism and transporter sciences at QPS. 

Hepatic Biosciences has also assumed responsibility for all GLP-compliant quality assurance and bioanalysis in support of The Hamner. In addition to augmenting existing Hamner research programs, QPS will focus on new business development for both organizations.

"Strengthening in vitro ADME within QPS is a logical extension of our bench-to-the-bedside strategy in bridging preclinical data to phase I by addressing drug-drug interaction concerns,” said Benjamin Chien, PhD, chairman, president and CEO of QPS Holdings. “The collaboration with The Hamner reinforces the QPS philosophy of providing outstanding science and services to our customers.  QPS is very pleased to collaborate with the many distinguished scientists within The Hamner.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.